Explore more publications!
Mississippi Healthcare Reporter
Submit Press Release

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 13, 2025

Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million
November 13, 2025

Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million

Indeterminate GlobeNewswire
BioStem Technologies Reports Third Quarter 2025 Financial Results
November 13, 2025

BioStem Technologies Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025

Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Amneal Receives U.S. FDA Approval for Iohexol Injection
November 13, 2025

Amneal Receives U.S. FDA Approval for Iohexol Injection

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025

Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
November 13, 2025

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Indeterminate GlobeNewswire
Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 13, 2025

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
November 13, 2025

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

Indeterminate GlobeNewswire
Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates
November 13, 2025

Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates

Indeterminate GlobeNewswire
Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025

Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
BioStem Technologies Announces Filing of Restated Financial Statements
November 13, 2025

BioStem Technologies Announces Filing of Restated Financial Statements

Indeterminate GlobeNewswire
ヌマブ・セラピューティクス (Numab Therapeutics) および科研製薬 (Kaken Pharmaceutical)、炎症性腸疾患 (IBD) における多特異性抗体NM81のライセンスおよび共同開発契約を発表
November 13, 2025

ヌマブ・セラピューティクス (Numab Therapeutics) および科研製薬 (Kaken Pharmaceutical)、炎症性腸疾患 (IBD) における多特異性抗体NM81のライセンスおよび共同開発契約を発表

Indeterminate GlobeNewswire
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
November 13, 2025

Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025

Indeterminate GlobeNewswire
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
November 13, 2025

Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call

Indeterminate GlobeNewswire
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
November 13, 2025

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

Indeterminate GlobeNewswire
Bioxytran Announces Initiation of Coverage of its Stock by Independent Research
November 13, 2025

Bioxytran Announces Initiation of Coverage of its Stock by Independent Research

Indeterminate GlobeNewswire
StoryCatch Partners Unveils Post-Acquisition Rebrand of EmpiraMed as StoryCatch Insights
November 13, 2025

StoryCatch Partners Unveils Post-Acquisition Rebrand of EmpiraMed as StoryCatch Insights

Indeterminate GlobeNewswire
Parsley Health Relaunches Longevity Labs to Turn Lab Results Into Real Action
November 13, 2025

Parsley Health Relaunches Longevity Labs to Turn Lab Results Into Real Action

Indeterminate GlobeNewswire
Did Congress Just Ban Hemp? Two Women Industry Leaders Say There’s Still Time to Get It Right
November 13, 2025

Did Congress Just Ban Hemp? Two Women Industry Leaders Say There’s Still Time to Get It Right

Indeterminate GlobeNewswire
Global Active Implantable Medical Devices Market Set to Reach New Heights at a CAGR of ~7% by 2032, Driven by Rising Chronic Disease Burden and Technological Advancements | DelveInsight
November 13, 2025

Global Active Implantable Medical Devices Market Set to Reach New Heights at a CAGR of ~7% by 2032, Driven by Rising Chronic Disease Burden and Technological Advancements | DelveInsight

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions